Polaris Research/Shop/Retatrutide 10mg
K-PEPsRetatrutide10mg · LYOBATCH VERIFIED

Weight loss · 10mg

Retatrutide 10mg

Also searched as: Reta peptide · Reta · R3ta peptide · Reda peptide · Ratatouille peptide · Retatrude · Retatrutide peptide

$159
#1 in weekly peptide rankings
1
Free express shipping Australia-wide
Quality certificate included
Sealed under argon
Reserved for 24h once ordered

Retatrutide is a triple-agonist research peptide studied for its activity across three of the most discussed metabolic targets in current literature: the GLP-1, GIP, and glucagon receptor pathways. Where earlier compounds addressed one or two of these receptors, retatrutide reaches all three, which is why it sits at the centre of appetite-signalling and metabolic-balance research. The 10mg vial is the standard entry format and divides cleanly into the reference aliquots most researchers use.This is the family where the foundations matter most. The metabolic literature is explicit that signalling compounds are studied alongside — not instead of — food, sleep, and movement, and the people who get the most from this category tend to be the ones who already have those baselines steady. Approach with patience: signalling compounds work with the body's own timelines, never against them.Every 10mg vial of retatrutide ships lyophilised (freeze-dried) with an independently verified batch certificate at ≥98% purity, which you can look up on the batch verification page using the batch number on the label. Bacteriostatic water is included so you can reconstitute on arrival — add it slowly down the wall of the vial, swirl gently, and never shake. Store the unopened vial refrigerated at 2–8°C; once reconstituted, keep the solution refrigerated and avoid repeated freeze-thaw cycles. Shipping is free Australia Post Express Australia-wide, sealed under argon, with a 24-hour payment reservation holding your stock from the moment you order.

Formal name
Retatrutide
CAS number
2381089-83-2
Purity
99.6% · independently verified
Description
Triple-agonist research peptide targeting GLP-1, GIP and glucagon receptor pathways, positioned for metabolic and appetite-signalling research.
Research focus
Metabolic research, appetite signalling, body-composition pathways and glucose-handling models.
Suggested use
Reference plan: 2 mg aliquots on a once-weekly research cadence. Begin conservatively and only escalate if the protocol has a qualified reason.
Doses per vial
5 x 2 mg reference aliquots.
Concentration
2 mg per reference aliquot from a 10 mg vial.
Notes
Investigational compound; strongest human data are obesity trials, not general wellness use.
Weekly ranking

#1 most popular research peptide

View ranking

Retatrutide keeps the top spot because metabolic peptide interest is still the clearest high-intent search pattern in Australia.

Search intent

High-intent searches for GLP-1, GIP, and glucagon-pathway research peptides.

Demand signal

Consistent product views, repeat catalogue searches, and strong add-to-cart intent.

retatrutide australiaretatrutide peptideretatrutide 10mgretatrutide 20mg
Updated 22 June 2026

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with bacteriostatic water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence overview on reptides.co

Independent third-party research on reptides.co - not affiliated with Polaris Research. Research reference only, not medical advice.

Related Reading

From the Library

$159